Calcium Gluconate 32.82;
Calcium Glycerophosphate 8.13;
Magnesium Chloride Hexahydrate 4.18.
Excipients: boric acid, sodium citrate,water for injection.

Pharmaceutical Properties

The action of Calcenon is determined by effects of its components.

Calcium stimulates the cardiovascular system and the reduction of protein dispersibility and blood vessel permeability, activates blood coagulation processes, is involved in the formation of bony tissue (preventing the development of rickets and osteopathy), regulates nerve conduction and muscle contraction processes, and has a general tonic and antitoxic effect.

Phosphorus is found in nucleoproteins and phospholipids, it stimulates anabolism processes and has a favourable effect on the tissue metabolism.

Magnesium has a beneficial effect on the exchange of phosphorus and carbohydrates, acting as a coenzyme. A magnesium deficiency in animals causes excessive nervous excitation. When administered as part of a combination therapy, it blocks the nerve and muscle transmission and prevents the development of spasms.


Calcenon is indicated in agricultural animals for prevention and treatment of:

tetany ( tetany during pregnancy and lactation periods, transit tetany, grass sickness, etc);
postparturient paresis and paresis caused by calcium or phosphorus deficiency;
calcium/phosporus/magnesium exchange disorders (rickets, osteopathy, halisteresis, pregnancy, etc);
lead/fluorine/oxalic acid poisoning (as an adjuvant therapy in combination with other
toxicosis, allergy, bleeding diathesis, hematuria, hemoglobulinuria.

Animals with hypercalcaemia, severe renal disorders, auricular fibrillation, or hypersensitivity to the medicine components should not receive Calcenon.

Concomitant use of Calcenon with digitalis medicines or vitamin D and similar products is not recommended.

Adverse Effects

No data available.


Hypercalcaemia (in the event of overdose) may cause anorexia, muscle pains, nausea, vomiting, thirst, and polyuria. In the most severe cases, hypercalcaemia may lead to bradycardia andcardiac dysrhythmia. No specific antidote is known. Treatment should be case specific.


Solution in glass bottles of 100 ml.

© Use of materials is allowed provided the active indexed links to